News

Sofvasc V

Sofvasc V

20 Apr, 2011

Sofvasc-V, a combination of amlodipine, a dihydropyridine calcium channel blocker (CCB) and valsartan, an angiotensin II receptor blocker (ARB) is indicated for the treatment of hypertension in patients not adequately controlled on monotherapy or as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.

 

Sitemap | Contact Us Copyright © 2017 Wilson's Pharmaceuticals. All Rights Reserved.